CD14 C (-260)T polymorphism, atherosclerosis, elderly: Role of cytokines and metallothioneins

International Journal of Cardiology

Volumn 120, Issue 1, 2007, Pages 45-51

  Giacconi, Robertina ^a   Caruso, Calogero ^b   Lio, Domenico ^b   Muti, Elisa ^a   Cipriano, Catia ^a   Costarelli, Laura ^a   Saba, Vittorio ^a   Gasparini, Nazzarena ^a   Malavolta, Marco ^a   Mocchegiani, Eugenio ^a  

^a INRCA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Atherosclerosis; CD14; Cytokines; Inflammation; Methallothionein; Polymorphism

Indexed keywords

CD14 ANTIGEN; CYTOKINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; INTERLEUKIN 6; LYMPHOCYTE ANTIGEN RECEPTOR; METALLOTHIONEIN; METALLOTHIONEIN II; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANTIGEN DETECTION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE SEVERITY; FEMALE; FREQUENCY ANALYSIS; GENE EXPRESSION PROFILING; GENETIC POLYMORPHISM; GENOTYPE; GERIATRIC ASSESSMENT; HOMOZYGOTE; HUMAN; HYPERCHOLESTEROLEMIA; ITALY; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ANTIGENS, CD14; ATHEROSCLEROSIS; CAROTID STENOSIS; CASE-CONTROL STUDIES; CHOLESTEROL; CYTOKINES; FEMALE; HUMANS; ITALY; MALE; METALLOTHIONEIN; POLYMORPHISM, GENETIC; RNA, MESSENGER;

EID: 34347259178     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.08.035     Document Type: Article

References (48)

1. Ulevitch R.J., and Tobias P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13 (1995) 437-457
2. Andreotti F., Porto I., Crea F., and Maseri A. Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart 87 (2002) 107-112
3. Guha M., and Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13 (2001) 85-94
4. LeVan T.D., Bloom J.W., Bailey T.J., et al. Common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 167 (2001) 5838-5844
5. Hubacek J.A., Rothe G., Pit'ha J., et al. C[-260]->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99 (1999) 3218-3220
6. Arroyo-Espliguero R., El-Sharnouby K., Vazquez-Rey E., Kalidas K., Jeffery S., and Kaski J.C. CD14 C(-260)T promoter polymorphism and prevalence of acute coronary syndromes. Int J Cardiol 98 (2005) 307-312
7. Hohda S., Kimura A., Sasaoka T., et al. Association study of CD14 polymorphism with myocardial infarction in a Japanese population. Jpn Heart J 44 (2003) 613-622
8. Shimada K., Miyauchi K., Mokuno H., et al. Promoter polymorphism in the CD14 gene and concentration of soluble CD14 in patients with in-stent restenosis after elective coronary stenting. Int J Cardiol 94 (2004) 87-92
9. Miller Y.I., Viriyakosol S., Worrall D.S., Boullier A., Butler S., and Witztum J.L. Toll-like receptor 4-dependent and independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol 25 (2005) 1213-1239
10. Zee R.Y., Lindpaintner K., Struk B., Hennekens C.H., and Ridker P.M. A prospective evaluation of the CD14 C(-260)T gene polymorphism and the risk of myocardial infarction. Atherosclerosis 154 (2001) 699-702
11. Longobardo M.T., Cefalu A.B., Pezzino F., et al. The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction. Clin Exp Med 3 (2003) 161-165
12. Pugin J., Ulevitch R.J., and Tobias P.S. Activation of endothelial cells by endotoxin: direct versus indirect pathways and the role of CD14. Prog Clin Biol Res 392 (1995) 369-373
13. Loppnow H., Stelter F., Schonbeck U., et al. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14. Infect Immun 63 (1995) 1020-1026
14. Lo S.K., Cheung A., Zheng Q., and Silverstein R.L. Induction of tissue factor on monocytes by adhesion to endothelial cells. J Immunol 154 (1995) 4768-4777
15. Koenig W., Khuseyinova N., Hoffmann M.M., et al. CD14 C(-260)T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease. J Am Coll Cardiol 40 (2002) 34-42
16. Amar J., Ruidavets J.B., Bal dit Sollier C., et al. CD14 C(-260) T gene polymorphism, circulating soluble CD14 levels and arteriosclerosis. J Hypertens 22 (2004) 1523-1528
17. Libby P., Sukhova G., Lee R.T., and Galis Z.S. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol 25 Suppl 2 (1995) S9-S12
18. Giacconi R., Caruso C., Lio D., et al. 1267 HSP70-2 polymorphism as a risk factor for carotid plaque rupture and cerebral ischaemia in old type 2 diabetes-atherosclerotic patients. Mech Ageing Dev 126 (2005) 866-873
19. Ikeda U., Ito T., and Shimada K. Interleukin-6 and acute coronary syndrome. Clin Cardiol 24 (2001) 701-704
20. Young J.L., Libby P., and Schonbeck U. Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 88 (2002) 554-567
21. Kher N., and Marsh J.D. Pathobiology of atherosclerosis-a brief review. Semin Thromb Hemost 30 (2004) 665-672
22. Nath R., Kumar D., Li T., and Singal P.K. Metallothioneins, oxidative stress and the cardiovascular system. Toxicology 155 (2000) 17-26
23. Gobel H., van der Wal A.C., Teeling P., van der Loos C.M., and Becker A.E. Metallothionein in human atherosclerotic lesions: a scavenger mechanism for reactive oxygen species in the plaque?. Virchows Arch 437 (2000) 528-533
24. Ohsuzu F. The roles of cytokines, inflammation and immunity in vascular diseases. J Atheroscler Thromb 11 (2004) 313-321
25. Lio D., Scola L., Crivello A., et al. Gender-specific association between -1082 IL-10 promoter polymorphism and longevity. Genes Immun 3 (2002) 30-33
26. Faught W.E., Mattos M.A., van Bemmelen P.S., et al. Color-flow duplex scanning of carotid arteries: new velocity criteria based on receiver operator characteristic analysis for threshold stenoses used in the symptomatic and asymptomatic carotid trials. J Vasc Surg 19 (1994) 818-827
27. Giacconi R., Cipriano C., Albanese F., et al. The -174G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing. Exp Gerontol 39 (2004) 621-628
28. Jinawath A., Miyake S., Yanagisawa Y., Akiyama Y., and Yuasa Y. Transcriptional regulation of the human DNA methyltransferase 3A and 3B genes by Sp3 and Sp1 zinc finger proteins. Biochem J 385 (2005) 557-564
29. Pajkrt D., Doran J.E., Koster F., et al. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J Exp Med 184 (1996) 1601-1608
30. Ito D., Murata M., Tanahashi N., et al. Polymorphism in the promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease. Stroke 31 (2000) 2661-2664
31. Hung J., McQuillan B.M., Chapman C.M., Thompson P.L., and Beilby J.P. Promoter polymorphism of the gene for CD14 receptor is not associated with sub-clinical carotid atherosclerosis in a community population. Eur J Cardiovasc Prev Rehabil 11 (2004) 344-349
32. Azar R.R., Badaoui G., Sarkis A., et al. Effects of tirofiban and statins on high-sensitivity C-reactive protein, interleukin-6, and soluble CD40 ligand following percutaneous coronary interventions in patients with stable coronary artery disease. Am J Cardiol 95 (2005) 236-240
33. De Michele M., Iannuzzi A., Panico S., et al. Effect of high-density lipoprotein cholesterol levels on carotid artery geometry in a Mediterranean female population. Eur J Cardiovasc Prev Rehabil 11 (2004) 403-407
34. Sigurdardottir V., Fagerberg B., and Hulthe J. Preclinical atherosclerosis and inflammation in 61-year-old men with newly diagnosed diabetes and established diabetes. Diabetes Care 27 (2004) 880-884
35. Heesen M., Blomeke B., Schluter B., Heussen N., Rossaint R., and Kunz D. Lack of association between the -260 C->T promoter polymorphism of the endotoxin receptor CD14 gene and the CD14 density of unstimulated human monocytes and soluble CD14 plasma levels. Intensive Care Med 27 (2001) 1770-1775
36. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
37. Libby P., Geng Y.J., Aikawa M., et al. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 7 (1996) 330-335
38. Libby P., and Simon D.I. Inflammation and thrombosis: the clot thickens. Circulation 103 (2001) 1718-1720
39. Koukkunen H., Penttila K., Kemppainen A., et al. C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med 33 (2001) 37-47
40. Perez Fernandez R., and Kaski J.C. Interleukin-10 and coronary disease. Rev Esp Cardiol 55 (2002) 738-750
41. Waehre T., Halvorsen B., Damas J.K., et al. Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10. Eur J Clin Invest 32 (2002) 803-810
42. Lio D., Candore G., Crivello A., et al. Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J Med Genet 41 (2004) 790-794
43. Heeschen C., Dimmeler S., Hamm C.W., et al. CAPTURE Study Investigators. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107 (2003) 2109-2114
44. Balistreri C.R., Candore G., Colonna-Romano G., et al. Role of toll-like receptor 4 in acute myocardial infarction and longevity. JAMA 292 (2004) 2339-2340
45. Waelput W., Broekaert D., Vandekerckhove J., Brouckaert P., Tavernier J., and Libert C. A mediator role for metallothionein in tumor necrosis factor-induced lethal shock. J Exp Med 194 (2001) 1617-1624
46. Mocchegiani E., Giacconi R., Cipriano C., et al. MtmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lessons from very old mice and humans. Exp Gerontol 7 (2002) 349-357
47. Beattie J.H., and Kwun I.S. Is zinc deficiency a risk factor for atherosclerosis?. Br J Nutr 91 (2004) 177-181
48. Mocchegiani E., Giacconi R., Muti E., et al. Zinc, immune plasticity, aging, and successful aging: role of metallothionein. Ann N Y Acad Sci 1019 (2004) 127-134